PharVision Advisers, LLC: INGN position timeline

PharVision Advisers, LLC held 13,473 INGN shares at 2026-06-30 per its 13F-HR filed 2026-08-11.

the latest 13F is the newest step

1. period ended2026-06-30

   13F 13,473 shares

   Change vs previous 13F +13,473 shares

   1.64% of the 13F portfolio, value $86,901.

   13F-HR 0001420506-26-001505 filed by PharVision Advisers, LLC
   Filed 2026-08-11 (acceptance time not in the bulk data set), ingested 2026-10-06 09:57:27 UTC

   Acceptance time not in the bulk data set (spec §4.2).

2. period ended2026-03-31

   13F/A 0 shares

   Change vs previous 13F -55,240 shares

   13F-HR/A 0001420506-26-000909 filed by PharVision Advisers, LLC
   Filed 2026-05-11 (acceptance time not in the bulk data set), ingested 2026-10-06 09:58:43 UTC

   Acceptance time not in the bulk data set (spec §4.2).

   Exited: the 13F for this period no longer lists the position.

3. period ended2025-12-31

   13F 55,240 shares

   Change vs previous 13F +55,240 shares

   0.19% of the 13F portfolio, value $371,213.

   13F-HR 0001420506-26-000567 filed by PharVision Advisers, LLC
   Filed 2026-02-17 (acceptance time not in the bulk data set), ingested 2026-10-07 03:01:36 UTC

   Acceptance time not in the bulk data set (spec §4.2).

4. period ended2025-03-31

   13F 0 shares

   Change vs previous 13F -18,885 shares

   13F-HR 0001420506-25-001232 filed by PharVision Advisers, LLC
   Filed 2025-05-15 (acceptance time not in the bulk data set), ingested 2026-10-07 18:25:06 UTC

   Acceptance time not in the bulk data set (spec §4.2).

   Exited: the 13F for this period no longer lists the position.

5. period ended2024-12-31

   13F 18,885 shares

   Change vs previous 13F not available

   0.15% of the 13F portfolio, value $173,175.

   13F-HR 0001420506-25-000626 filed by PharVision Advisers, LLC
   Filed 2025-02-18 (acceptance time not in the bulk data set), ingested 2026-10-07 18:25:55 UTC

   Acceptance time not in the bulk data set (spec §4.2).